Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05032872 · ClinicalTrials.gov registry record · NA

Exergame Study for Family Caregivers

A NA study, sponsored by Brandeis University.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT05032872: Completed NA study, sponsored by Brandeis University.

NCT05032872 is a NA study that has completed, run by Brandeis University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05032872, a NA study, has completed, sponsored by Brandeis University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The goal of this study is to examine Go\&Grow as a social exergame intervention to increase physical activity and social support, to promote well-being in family caregivers, and to test social support and physical activity as mechanisms for the effects of the intervention.

Primary Outcome

Steps were automatically synced from the Fitbit for both conditions daily. Days with 500 or fewer recorded steps were coded as missing. Weekly step averages were calculated for weeks with 4 or more days not coded missing. The first two weeks of baseline steps were averaged to form the baseline step. Percent change of steps was calculated as the difference between the average weekly steps during the intervention (weeks 3-8) and baseline steps divided by baseline steps.

Interventions

  • BEHAVIORAL Control Group
  • BEHAVIORAL Social Exergame Treatment Group

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-08-16
Est. Completion 2022-04-30
Phase NA
Brandeis University

8 total trials

What the finished NCT05032872 record still lists

NCT05032872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.

NCT05032872 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05032872 about?

NCT05032872 is a clinical study titled "Exergame Study for Family Caregivers". The goal of this study is to examine Go\&Grow as a social exergame intervention to increase physical activity and social support, to promote well-being in family caregivers, and to test social support and physical activity as mechanisms for the effects of the intervention.

What is the current status of trial NCT05032872?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2021-08-16. Estimated completion is 2022-04-30.

What interventions are being tested in trial NCT05032872?

The interventions under investigation include: Control Group (BEHAVIORAL), Social Exergame Treatment Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT05032872?

This trial is sponsored by Brandeis University, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05032872's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05032872, the US trial registry maintained by the National Library of Medicine. NCT05032872 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.